195 related articles for article (PubMed ID: 34638301)
21. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
23. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.
Hara Y; Shiba N; Yoshida K; Yamato G; Kaburagi T; Shiraishi Y; Ohki K; Shiozawa Y; Kawamura M; Kawasaki H; Sotomatsu M; Takizawa T; Matsuo H; Shimada A; Kiyokawa N; Tomizawa D; Taga T; Ito E; Horibe K; Miyano S; Adachi S; Taki T; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2023 Jul; 62(7):412-422. PubMed ID: 37102302
[TBL] [Abstract][Full Text] [Related]
24. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
25. Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blasts.
Fenton M; Whiteside TL; Ferrone S; Boyiadzis M
Oncol Res; 2015; 22(2):117-21. PubMed ID: 25706398
[TBL] [Abstract][Full Text] [Related]
26. Detection of a Cryptic KMT2A/AFDN Gene Fusion [ins(6;11)(q27;q23q23)] in a Pediatric Patient with Newly Diagnosed Acute Myeloid Leukemia.
Berg HE; Greipp PT; Baughn LB; Falcon CP; Jackson CC; Peterson JF
Lab Med; 2022 Jul; 53(4):e95-e99. PubMed ID: 34894139
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
Xu J; Zhang Y; Hu J; Ren Y; Wang H
Hematology; 2020 Dec; 25(1):79-84. PubMed ID: 32019476
[No Abstract] [Full Text] [Related]
28. Comprehensive molecular understanding of pediatric acute myeloid leukemia.
Shiba N
Int J Hematol; 2023 Feb; 117(2):173-181. PubMed ID: 36653696
[TBL] [Abstract][Full Text] [Related]
29. Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group.
Marceau-Renaut A; Duployez N; Ducourneau B; Labopin M; Petit A; Rousseau A; Geffroy S; Bucci M; Cuccuini W; Fenneteau O; Ruminy P; Nelken B; Ducassou S; Gandemer V; Leblanc T; Michel G; Bertrand Y; Baruchel A; Leverger G; Preudhomme C; Lapillonne H
Hemasphere; 2018; 2(1):e31. PubMed ID: 31723759
[TBL] [Abstract][Full Text] [Related]
30. High
Zheng Y; Huang Y; Le S; Zheng H; Hua X; Chen Z; Feng X; Li C; Zheng M; Xu H; He Y; He X; Li J; Hu J
Front Oncol; 2021; 11():712747. PubMed ID: 34589425
[TBL] [Abstract][Full Text] [Related]
31. Analytical study of
Sepúlveda-Robles O; Jiménez-Hernández E; Domínguez-Catzín V; Gómez-Flores E; Martín-Trejo JA; Flores-Lujano J; Torres-Nava JR; Núñez-Enríquez JC; De Ita M; Medina-Sanson A; Mata-Rocha M; Morales-Castillo BA; Bravata-Alcántara JC; Nájera-Cortés AS; Sánchez-Escobar N; Peñaloza-Gonzalez JG; Espinosa-Elizondo RM; Flores-Villegas LV; Amador-Sanchez R; Orozco-Ruiz D; Pérez-Saldívar ML; Velázquez-Aviña MM; Merino-Pasaye LE; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; Bekker-Méndez VC; Jiménez-Morales S; Rangel-López A; Rosas-Vargas H; Mejía-Aranguré JM
Front Pediatr; 2022; 10():946690. PubMed ID: 36452349
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
[TBL] [Abstract][Full Text] [Related]
33. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia.
Shen Y; Zhu YM; Fan X; Shi JY; Wang QR; Yan XJ; Gu ZH; Wang YY; Chen B; Jiang CL; Yan H; Chen FF; Chen HM; Chen Z; Jin J; Chen SJ
Blood; 2011 Nov; 118(20):5593-603. PubMed ID: 21881046
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
[TBL] [Abstract][Full Text] [Related]
35. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract][Full Text] [Related]
36. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
[TBL] [Abstract][Full Text] [Related]
37. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract][Full Text] [Related]
38. Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.
Tregnago C; Benetton M; Da Ros A; Borella G; Longo G; Polato K; Francescato S; Biffi A; Pigazzi M
Front Pharmacol; 2021; 12():820191. PubMed ID: 35153769
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of Genomic Landscape in Patients with Acute Myeloid Leukemia].
Wang SM; Zheng HJ; Tian Y; Zhang JM; Yao JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):797-801. PubMed ID: 32552938
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of
Ye W; Ma M; Wu X; Deng J; Liu X; Zheng X; Gong Y
BMJ Open; 2023 Feb; 13(2):e062376. PubMed ID: 36725100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
